Nonprogressive CMV retinitis in AIDS patients with protease inhibitors therapy for AIDS.
- 1 January 1997
- journal article
- case report
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 5 (4) , 279-282
- https://doi.org/10.3109/09273949709085069
Abstract
Cytomegalovirus (CMV) retinitis is the most common opportunistic viral infection in acquired immunodeficiency syndrome (AIDS) patients with a low CD4+ count. Without specific treatment, the disease is an important cause of blindness. We report two cases of AIDS with nonprogressive CMV retinitis after undergoing a combined antiHIV treatment schedule including at least one protease inhibitor. The treatment was associated with an increase in circulating CD4+ lymphocytes. This newly available antiviral combination may well prevent the recurrence of CMV disease and decrease the morbidity of CMV retinitis.Keywords
This publication has 5 references indexed in Scilit:
- Antiretroviral Therapy for HIV Infection in 1996JAMA, 1996
- Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and ZalcitabineNew England Journal of Medicine, 1996
- Combination Foscarnet and Ganciclovir Therapy vs Monotherapy for the Treatment of Relapsed Cytomegalovirus Retinitis in Patients With AIDSArchives of Ophthalmology (1950), 1996
- Cytomegalovirus Retinitis and Low CD4+ T-Lymphocyte CountsNew England Journal of Medicine, 1995
- Correlation Between CD4+ Counts and Prevalence of Cytomegalovirus Retinitis and Human Immunodeficiency Virus--related Noninfectious Retinal Vasculopathy in Patients With Acquired Immunodeficiency SyndromeAmerican Journal of Ophthalmology, 1993